In vitro drug metabolism of green tea catechins in Human, Monkey, Dog, Rat and Mouse Hepatocytes

Drug Metabolism Letters

Volumn 6, Issue 2, 2012, Pages 73-93

  Chen, Wendy W ^a   Qin, Geng Yao ^a   Zhang, Ting ^a   Feng, Wan Yong ^a  

^a WUXI APPTEC   (China)

Author keywords

Catechins; Dogs; Hepatocytes; Humans; Metabolism; Mice; Monkeys; Rats

Indexed keywords

EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHEMICAL REACTION; CRYOPRESERVATION; DOG; DRUG GLUCURONIDATION; DRUG HYDROLYSIS; DRUG METABOLISM; DRUG SULFATION; HAPLORHINI; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; ISOMERIZATION; LIVER CELL; LIVER CYTOSOL; LIVER MICROSOME; METHYLATION; MOUSE; NONHUMAN; OXIDATION; POLYMERIZATION; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; TEA;

ANIMALS; CATECHIN; DOGS; FEMALE; HEPATOCYTES; HUMANS; MACACA FASCICULARIS; MALE; MICE; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY; TEA;

CANIS FAMILIARIS; MUS; RATTUS;

EID: 84864354445     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231212804096709     Document Type: Article

References (51)

1. Yang, C.S.; Landau, J.M. Effects of tea consumption on nutrition and health. J. Nutr., 2000, 130, 2409-2412.
2. Mckay, D.L.; Blumberg, J.B. The role of tea in human health: an update. J. Am. Coll. Nutr., 2002, 21, 1-13.
3. Williamson, G. The use of flavanoid aglycones in in vitro systems to test biological activities: based on bioavailability data, is this a valid approach? Phytochem. Rev., 2002, 1, 215-222.
4. Kroon, P.A.; Clifford, M.N.; Crozier, A.; Day, A.J.; Donovan, J.L.; Manach C.; Williamson, G. How should we assess the effects of exposure to dietary polyphenons in vitro? Am. J. Clin. Nutr., 2004, 80, 15-21.
5. Sang, S.; Lambert, J.D.; Ho, C.T.; Yang, C.S. The chemistry and biotransformation of tea constituents. Pharmacol. Res., 2011, 64, 87-99.
6. Wiseman, S.; Mulder, T.; Rietveld, A. Tea flavonoids: bioavailability in vivo and effects on cell signaling pathways in vitro. Antio. Redox Signal, 2001, 3, 1009-1021.
7. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, J. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr., 2004, 79(5), 727-747.
8. Manach, C.; Donovan, J.L. Pharmacokinetics and metabolism of dietary flavanoids in humans. Free Radic. Res., 2004, 38, 771-785.
9. Scalbert, A.; Morand, C.; Manach, C.; Remesy, C. Absorption and metabolism of polyphenols in the gut and impact on health. Biomed. Pharmacother., 2002, 56, 276-282.
10. Spencer, J.P. Metabolism of tea flavonoids in the gastrointestinal tract. J. Nutr., 2003, 133, 3255S-3261S.
11. Walle, T. Absorption and metabolism of flavonoids. Free Radical Biol. Med., 2004, 36, 829-837.
12. Spencer, J.P.; Abd-el-Mohsen, M.M.; Rice-Evans, C. Cellular uptake and metabolism of flavanoids and their metabolites: implications for their bioactivity. Arch. Biochem. Biophys., 2004, 423, 148-161.
13. Zhou, S.; Gao, Y.H.; Jiang, W.Q.; Huang, M.; Xu, A.L.; Paxton, J.M. Interactions of herbs with cytochrome P450. Drug Metab. Rev., 2003, 35, 35-98.
14. Lambert, J.D.; Sang, S.M.; Lu, A.Y.H.; Yang, C.S. Metabolism of dietary polyphenols and possible interactions with drugs. Curr. Drug Metab., 2007, 8, 499-507.
15. Feng, W.Y. Metabolism of green tea catechins: an overview. Curr. Drug Metab., 2006, 7, 755-809.
16. Feng, W.Y. Metabolic fate of green tea catechins in humans. Tea in Health and Disease Prevention, edited by P. R Preedy, Academic Press, 2012, 953-969.
17. Feng, W.Y. Drug interactions with green tea catechins in humans. Tea in Health and Disease Prevention, edited by P. R Preedy, Academic Press, 2012, 971-991.
18. Sarma, D.N.; Barrett, M.L.; Chavez, M.L.; Gardiner, P.; Ko, R.; Mahady, G.B.; Marles, R.J.; Pellicore, L.S.; Giancaspro, G.I.; Dog, T.L. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf., 2008, 31, 469-484.
19. Mazzanti, G.; Menniti-Ippolito, F.; Moro, P.A.; Cassetti, F.; Raschetti, R.; Santuccio, C.; Mastrangelo, S. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur. J. Clin. Pharmacol., 2009, 65, 331-341.
20. Kapetanovic, I.M.; Crowell, J.A.; Krishnaraj, R.; Zakharov, A.; Lindeblad, M.; Lyubimov, A. Exposure and toxicity of green tea polyphenols in fasted and non-fasted dogs. Toxicol., 2009, 260(1-3), 28-36.
21. Wu, K.M.; Yao, J.; Boring, D. Green tea extract-induced lethal toxicity in fasted but not in nonfasted dogs. Int. J. Toxicol., 2011, 30, 19-20.
22. Sang, S.; Lambert, J.D.; Hong, J.; Tian, S.; Lee, M.J.; Stark, R.E.; Ho, C.T.; Yang, C.S. Synthesis and structure identification of thiol conjugates of (-)-epigallocatechin gallate and their urinary levels in mice. Chem. Res. Toxicol., 2005, 18, 1762-9.
23. Zhu, B.T.; Patel, U.K.; Cai, M.X.; Conney, A.H. O-methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase. Drug Metab. Dispos., 2000, 28, 1024-1030.
24. Vaidyanathan, J.B.; Walle, T. Glucuronidation and sulfation of the tea flavanoid (-)-epicatechin by the human and rat enzymes. Drug Metab. Dispos., 2002, 30, 897-903.
25. Das, N.P. Studies on flavonoid metabolism, absorption and metabolism of (+)-catechin in man. Biochem. Pharmacol., 1971, 20, 3435-3445.
26. Hackett, A.M.; Griffiths, L.A.; Broillet, A.; Wermeille, M. The metabolism and excretion of (+)-[14C]cyanidanol-3 in man following oral administration. Xenobiotica, 1983, 13, 279-286.
27. Wermeille, M.; Terin, E.; Griffiths, L.A. Identification of the major urinary metabolites of (+)-catechin and 3-O-methyl-(+)-catechin in man. Eur. J. Drug Metab. Pharmacokinet, 1983, 8, 77-84.
28. Meng, X.; Shang, S.; Zhu, N.; Lu, H.; Sheng, S.; Lee, M.J.; Ho, C.T.; Yang, C.S. Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chem. Res. Toxicol., 2002, 15, 1042-1050.
29. Mckay, D.L.; Blumberg, J.B. The role of tea in human health: an update. J. Am. Coll. Nutr., 2002, 21, 1-13.
30. Zhu, B.T.; Patel, U.K.; Cai, M.X.; Lee, A.J.; Conney, A.H. Rapid conversion of tea catechins to monomethylated products by rat liver cytosolic catechol-O-methyltransferase. Xenobiotica, 2001, 31(12), 879-890.
31. Kuhnle, G.; Spencer, J.P.; Schoeter, H.; Shenoy, B.; Debnam, E.S.; Srai, S.K.; Rice-Evans, C.; Hahn, U. Epicatechin and catechin are O-methylated and glucuronidated in the small intestine. Biochem. Biophys. Res. Commun., 2000, 277(2), 507-512.
32. Moridani, M.Y; Scobie, H.; Salehi, P.; O'Brien, P.J. Catechin metabolism: glutathione conjugate formation catalyzed by tyrosinase, peroxidase, and cytochrome P450. Chem. Res. Toxicol., 2001, 14, 841-8.
33. Baba, S.; Osakabe, N.; Natsume, M.; Muto, Y.; Takizawa, T.; Terao, J. In vivo comparison of the bioavailability of (+)-catechin, (-)-epicatechin and their mixture in orally administered rats. J. Nutr., 2001, 131(11), 2885-2891.
34. Okushio, K.; Suzuki, M.; Matsumoto, N.; Nanjo, F.; Hara, Y. Identification of (-)-epicatechin metabolites and their metabolic fate in the rat. Drug Metab. Dispos., 1999, 27(2), 309-316.
35. Scheline, R.R. CRC Handbook of Mammaliam Metabolism of Plant Compounds, CRC Press Inc., Boca Raton, FL., 1991, pp. 279-284.
36. Manach, C.; Texier, O.; Morand, C.; Crespy, V.; Régérat, F.; Demigné, C.; Rémésy, C. Comparison of the bioavailability of quercetin and catechin in rats. Free Radic. Biol. Med., 1999, 27(11-12), 1259-1266.
37. Harada, M.; Kan Y.; Naoki H.; Fukui, Y.; Kageyama, N.; Nakai, M.; Miki, W.; Kiso, Y. Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (-)-epicatechin. Biosci. Biotechnol. Biochem., 1999, 63(6), 973-977.
38. Donovan, J.L.; Crespy, V.; Manach, C.; Morand, C.; Besson, C.; Scalbert, A.; Remesy, C. Catechin is metabolized by both the small intestine and liver of rats. J. Nutr., 2001, 131(6), 1753-1757.
39. Li, C.; Meng, X.F.; Winnik, B.; Lee, M.J.; Lu, H.; Sheng, S.; Buckley, B.; Yang, C.S. Analysis of urinary metabolites of tea catechins by liquid chromatography/electrospray ionization mass spectrometry. Chem. Res. Toxicol., 2001, 14(6), 702-707.
40. Piskula, M.K.; Terao, J. Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues. J. Nutr., 1998, 128(7), 1172-1178.
41. Baba, S.; Osakabe, N.; Natsume, M.; Muto, Y.; Takizawa, T.; Terao, J. Absorption and urinary excretion of (-)-epicatechin after administration of different levels of cocoa powder or (-)-epicatechin in rats. J. Agric. Food Chem., 2001, 49(12), 6050-6056.
42. Chow, H.H.; Hakim, I.A.; Vining, D.R.; Crowell, J.A.; Ranger-Moore, J.; Chew, W.M.; Celaya, C.A.; Rodney, S.R.; Hara, Y.; Alberts, D.S. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin. Cancer Res., 2005, 11(12), 4627-33.
43. van Amelsvoort, J.M.; van hof, K.H.; Mathot, J.N.; Mulder, T.P.; Wiersma, A.; Tijburg, L.B. Plasma concentrations of individual tea catechins after a single oral dose to humans. Xenobiotica, 2001, 31, 891-901.
44. Okushio, K.; Suzuki, M.; Matsumoto, N.; Nanjo, F.; Hara, Y. Biosci. Methylation of tea catechins by rat liver homogenates. Biotechnol. Biochem., 1999, 63, 430-432.
45. Kohri, T.; Suzuki, M.; Nanjo, F. Identification of metabolites of (-)-epicatechin gallate and their metabolic fate in the rat. J. Agric. Food Chem., 2003, 51(18), 5561-6.
46. Hong, J.; Lu, H.; Meng, X.; Ryu, J.H.; Hara, Y.; Yang, C.S. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res., 2002, 62(24), 7241-6.
47. Tamura, M.; Yoshino, K. Degradation of tea polyphenols in alkaline solutions and antioxidant activity. J. Ecotech. Res., 1997, 3, 263-266.
48. Yoshino, K.; Suzuki, M.; Sasaki, K.; Miyase, T.; Sano, M. Formation of antioxidants from (-)-epigallocatechin gallate in mild alkaline fluids, such as authentic intestinal juice and mouse plasma. J. Nutr. Biochem., 1999, 10(4), 223-9.
49. Naasani, I.; Oh-Hashi, F.; Oh-Hara, T.; Feng, W.Y.; Johnston, J.; Chan, K.; Tsuruo, T. Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res., 2003, 63(4), 824-30.
50. Mizooku, Y.; Yoshikawa, M.; Tsuneyoshi, T.; Arakawa, R. Analysis of oxidized epigallocatechin gallate by liquid chromatography/mass spectrometry. Rapid Commun. Mass Spectrom., 2003, 17(16), 1915-8.
51. Zhang, L.; Zheng, Y.; Chow, M.S.; Zuo, Z. Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model. Int. J. Pharm., 2004, 287(1-2), 1-12.